PATENT CLAIM ANALYSIS

Application Number: 16028257
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-03
Patent Classification: ["548", "515000"]

Abstract:
The invention provides novel, multiply-substituted 1-aryl-3-azabicyclo[3.1.0]hexanes, and related processes and intermediates for preparing these compounds, as well as compositions and methods employing these compounds for the treatment and/or prevention of central nervous system (CNS) disorders, including depression and anxiety.

Claim (Index 98):
The compound according to  claim 97 , wherein the compound is:\n 1-(naphthalen-1-yl)-3-aza-bicyclo[3.1.0]hexane; 3-methyl-1-(naphthalen-1-yl)-3-aza-bicyclo[3.1.0]hexane; 1-(1-fluoronaphthalen-4-yl)-3-aza-bicyclo[3.1.0]hexane; 1-(1-fluoronaphthalen-4-yl)-3-methyl-3-aza-bicyclo[3.1.0]hexane; 1-(1-methylnaphthalen-4-yl)-3-aza-bicyclo[3.1.0]hexane; or 3-methyl-1-(1-methylnaphthalen-4-yl)-3-aza-bicyclo[3.1.0]hexane; or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 37.0
- Percentile: 95.0
- Lexical Diversity: 1.25
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14929361', '13887367', '15648424', '14802802', '14494512']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8267558494802273
- 35 USC 102 Novelty (BERT): 0.6440428525674087
- Combined Prediction Score: 0.8084845497889455
- Mean Citation Score: 558.0055440000001
- Max Citation Score: 615.3233
- Similarity Product: 598.6502961176336

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test